Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Relenza launched in U.K. in time for this year's flu season

Sep. 9, 1999

AS-924, a newly synthesized bifunctional ceftizoxime prodrug, shows good oral absorption

Sep. 9, 1999

Micrologix Biotech receives fast track designation for antimicrobial product

Sep. 8, 1999

Novel antibiotics targeting bacterial cell wall biosynthesis synthesized by Incara

Sep. 8, 1999

Pyrimidine derivatives from Tularik useful for CMV infections

Sep. 8, 1999

Oxazolidinones with broad-spectrum activity claimed by Bayer

Sep. 7, 1999

Orally active nucleoside prodrugs for HBV and HIV infections designed at Medivir

Sep. 7, 1999

Novel antimycotic NND-502 assessed in systemic and lung infection models

Sep. 7, 1999

GPC and Novalon collaboration for discovery of broad-spectrum antibiotics

Sep. 7, 1999

New 4-pyrrolidinylthio carbapenem with balanced spectrum chosen for further studies

Sep. 6, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...